Shigella

Explore clinical trials studying Shigella. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Shigella trial results

Recruiting

The Impact of Shigellosis and Recommended Treatment in Children

NCT07433426

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Diarrhea, +15 more
Locations: icddr,b Matlab Hospital Chāndpur, Bangladesh

icddr,b Hospital Dhaka, Bangladesh

Matero Level 1 Hospital Lusaka, Zambia

Arthur Davidson Children's Hospital Ndola, Zambia

View Trial Details

Recruiting

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

NCT07205926

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Diarrhea, +13 more
Locations: Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States

View Trial Details

Recruiting

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

NCT07049159

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +9 more
Locations: Center for Immunization Research Baltimore, Maryland, United States

View Trial Details

Completed

Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

NCT04078022

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +9 more
Locations: University of Maryland, Baltimore, Center for Vaccine Development and Global Health Baltimore, Maryland, United States

View Trial Details

Completed

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

NCT01531530

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +9 more
Locations: Shin Nippon Biomedical Laboratories, LTD. (SNBL) Inpatient Facility Baltimore, Maryland, United States

University of Maryland, Baltimore Center for Vaccine Development Baltimore, Maryland, United States

View Trial Details

Completed

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

NCT01080716

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Diarrhea, +13 more
Locations: Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand

View Trial Details

Active, Not Recruiting

Enterics for Global Health (EFGH)

NCT06047821

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Child, +14 more
Locations: Dhaka Medical College Hospital Dhaka, Bangladesh

EFGH Field Clinic Dhaka, Bangladesh

icddr,b Dhaka Hospital Dhaka, Bangladesh

Mugda Medical College Hospital Dhaka, Bangladesh

View all 33 locations

View Trial Details

Shigella

Shigella trial results

The Impact of Shigellosis and Recommended Treatment in Children

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

Enterics for Global Health (EFGH)

Related conditions